Volcano eyes record 2012 revenue; Philips snags 510(k) for respiratory tech;

 @FierceMedDev: JPM: T2 readies pivotal trial for Candida assay. Story | Follow @FierceMedDev

@MarkHFierce: A new NC startup wants to grow replacement corneas from donor cells and scaffolding. Story | Follow @MarkHFierce

 @DamianFierce: Fierce 15'er CardioKinetix is kicking off a pivotal trial for its heart-failure tech. Article | Follow @DamianFierce

> Monteris Medical raised $7.8 million to advance commercialization efforts for its NeuroBlate system, an MRI-guided laser probe designed to kill brain cancer tumors. Story

> Sony ($SNE) said it is considering selling its battery business in order to focus its energies, in part, on expanding its medical devices segment and revive television sales. Story

> Volcano ($VOLC) is expecting to have made $381.9 million in 2012 revenue once everything's counted, notching a record for the devicemaker. News

> Philips' ($PHG) Respironics unit won 510(k) clearance for CoughAssist T70, an airway-clearance device designed to minimize the risk of pneumonia and infections. Release

> Teleflex ($TFX), a company focused on critical care medical devices and surgical tools, has two new three-year deals to provide group purchasing organization Premier with a wide range of surgical instruments. Item

> Excelsior Medical inked a distribution deal with an Italian company to sell its catheter maintenance product line in the country. Item

Biotech News

 @FierceBiotech: From FierceVaccines.com: India's vaccine prices soar as private companies gain ground. Story | Follow @FierceBiotech

@JohnCFierce: Sanofi's case for R&D turnaround includes a few setbacks for cancer, MS - coming up at JPM13 pipeline review. News | Follow @JohnCFierce

@RyanMFierce: Third Rock selling a preclinical stage portfolio company is interesting. It's TRV's 2nd exit, and they're gonna need wins to raise more $$. | Follow @RyanMFierce

> Boehringer tosses back rights to one of Lilly's key PhIII diabetes programs. News

> Bob Langer biotech lands first big biopharma deal with Amgen. Story

> Shire gambles on one-man biotech startup to gain ultra-orphan drug. Report

Pharma News

@FiercePharma: Allergan eager to offload its obesity business (Lap-Band, etc) this quarter. PrivateEquity in on the hunt, CEO says. More | Follow @FiercePharma

@EricPFierce: Warburg Pincus' $195 million deal for JHP says something about the market for sterile injectable drugs. Story | Follow @EricPFierce

 @AlisonBFierce:  Rates of HPV-related cancers remain stubbornly high in the United States. More | Follow @AlisonBFierce

> Beeping bottle caps, videos attack drug adherence. Report

> Novartis CEO shopping for bolt-on deals at $4B, tops. News

Pharma Manufacturing News

> Novartis finds blister packs sell more drugs. Story

> Lonza doubling ADC capacity at Visp. Report

> Malaysia's location, domestic market draw Ranbaxy, Cipla, others. Article

> Exela investing in North Carolina plant. News

Biotech Research News

> Mouse results unlock metformin's secrets. Story

> Addex preclinical drug slows inherited neuropathy. News

> Using gene therapy to fix a scarred heart. Report

> Cell transplant gives blind mice their sight back. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

Drug-pricing watchdog ICER has partnered with medical data firm Aetion to help analyze the real-world performance of different treatments.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.